<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39465704</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>40</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>04</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Utilizing press needle acupuncture to treat mild-to-moderate COVID-19: A single-blind, randomized controlled trial.</ArticleTitle><Pagination><StartPage>e39810</StartPage><MedlinePgn>e39810</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e39810</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000039810</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In China, acupuncture has been employed as an adjunctive therapy for coronavirus disease 2019 (COVID-19). Press needle acupuncture is a special type of acupuncture that provides prolonged stimulation to acupuncture points and simultaneously reduces the pain associated with traditional acupuncture. This study assessed the effectiveness of integrating press needles alongside pharmacologic treatment in patients with mild-to-moderate COVID-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients hospitalized with mild-to-moderate COVID-19 symptoms between December 2022 and January 2023 were included in the study. The enrolled patients were randomly assigned to receive pharmacologic treatment alone (control group) or both pharmacologic treatment and press needle acupuncture (intervention group). Patients were evaluated for clinical outcomes, including symptom scores, deterioration rates, fever durations, and nucleic acid test results. The patients' complete blood count and C-reactive protein levels were also analyzed using venous blood samples both before and after treatment.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Both groups exhibited a reduction in clinical symptom scores, but symptoms regressed faster in the intervention group. Nucleic acid test negativity was achieved faster in the intervention group than in the control group. The intervention group also had a lower deterioration rate. Furthermore, the increase in the lymphocyte count and decrease in C-reactive protein levels following treatment were more pronounced in the intervention group than in the control group.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study suggests that utilizing press needle acupuncture as an adjunct to pharmacologic treatment can be effective in patients with mild-to-moderate COVID-19 symptoms.</AbstractText><CopyrightInformation>Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Jiawei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Baiyun Branch, NanFang Hospital, Southern Medical University, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Weizhen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>NanFang Hospital, Southern Medical University, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qie</LastName><ForeName>Beibei</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Baiyun Branch, NanFang Hospital, Southern Medical University, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Yuhua</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Taihe Branch, NanFang Hospital, Southern Medical University, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Binbin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Guangdong Work Injury Rehabilitation Hospital, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Cheng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Baiyun Branch, NanFang Hospital, Southern Medical University, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Wenwei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Baiyun Branch, NanFang Hospital, Southern Medical University, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Huanwen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Baiyun Branch, NanFang Hospital, Southern Medical University, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Southern Medical University, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Yaqiu</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0009-0001-8447-5788</Identifier><AffiliationInfo><Affiliation>Baiyun Branch, NanFang Hospital, Southern Medical University, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>BYYZ23005</GrantID><Agency>the President Foundation of Nanfang Hospital Baiyun Branch, Southern Medical University</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9007-41-4</RegistryNumber><NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015670" MajorTopicYN="Y">Acupuncture Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="N">COVID-19 Drug Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015669" MajorTopicYN="N">Acupuncture Points</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009339" MajorTopicYN="N">Needles</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>12</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>12</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>8</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39465704</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000039810</ArticleId><ArticleId IdType="pii">00005792-202410040-00013</ArticleId><ArticleId IdType="pmc">PMC11460845</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dong E, Ratcliff J, Goyea TD, et al. . The Johns Hopkins University Center for systems science and engineering COVID-19 dashboard: data collection process, challenges faced, and lessons learned. Lancet Infect Dis. 2022;22:e370–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9432867</ArticleId><ArticleId IdType="pubmed">36057267</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Rio C, Malani PN. COVID-19-new insights on a rapidly changing epidemic. JAMA. 2020;323:1339–40.</Citation><ArticleIdList><ArticleId IdType="pubmed">32108857</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K. Is traditional Chinese medicine useful in the treatment of COVID-19? Am J Emerg Med. 2020;38:2238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7138187</ArticleId><ArticleId IdType="pubmed">32245701</ArticleId></ArticleIdList></Reference><Reference><Citation>von Trott P, Oei SL, Ramsenthaler C. Acupuncture for breathlessness in advanced diseases: a systematic review and meta-analysis. J Pain Symptom Manage. 2020;59:327–38.e3.</Citation><ArticleIdList><ArticleId IdType="pubmed">31539602</ArticleId></ArticleIdList></Reference><Reference><Citation>China NHCotPsRo. Guideline of diagnosis and treatment for new coronavirus pneumonia (Interim version 9). 2022.</Citation></Reference><Reference><Citation>China NHCotPsRo. Guideline of diagnosis and treatment for new coronavirus pneumonia (Interim version 10). 2023.</Citation></Reference><Reference><Citation>Wang C, Liu B, Liu Y, He L, Li H, Liu J. Analysis on the concepts related to adverse events and adverse reactions of acupuncture. Zhongguo Zhen Jiu. 2018;38:87–90.</Citation><ArticleIdList><ArticleId IdType="pubmed">29354943</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B, Wang H, Zhou ZY, Chang XR, Zhang W, Liu BY. Analysis on the theory and clinical ideas of acupuncture and moxibustion for the prevention and treatment of coronavirus disease 2019. Zhongguo Zhen Jiu. 2020;40:571–5.</Citation><ArticleIdList><ArticleId IdType="pubmed">32538003</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Zhan J, Wen H, et al. . Current state of research about acupuncture for the treatment of COVID-19: a scoping review. Integr Med Res. 2021;10:100801.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8516141</ArticleId><ArticleId IdType="pubmed">34664024</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan WX, Fan AY, Chen S, Alemi SF. Acupuncture modulates immunity in sepsis: toward a science-based protocol. Auton Neurosci. 2021;232:102793.</Citation><ArticleIdList><ArticleId IdType="pubmed">33684727</ArticleId></ArticleIdList></Reference><Reference><Citation>Alipour R, Jamalimoghadamsiahkali S, Karimi M, et al. . Acupuncture or cupping plus standard care versus standard care in moderate to severe COVID-19 patients: an assessor-blinded, randomized, controlled trial. Integr Med Res. 2022;11:100898.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9617672</ArticleId><ArticleId IdType="pubmed">36337766</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Li Y, Xu M, et al. . Summary of the experience of Shenzhen traditional Chinese medicine team supporting Hubei in treating COVID-19 in Leishenshan hospital. J Pract Tradit Chin Intern Med. 2021;35:83–5.</Citation></Reference><Reference><Citation>Wang YZ, Li B, Wang LP, et al. . Acupuncture as adjuvant therapy for 32 cases of coronavirus disease 2019. Zhongguo Zhen Jiu. 2022;42:634–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">35712947</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong Y, Shi X, Zhang Y, et al. . To explore the clinical application and practice of acupuncture therapy in coronavirus disease 2019. Chin Acupunct Moxibustion. 2021;41:142–4.</Citation></Reference><Reference><Citation>Zhang K, Li Y, Tang Q. Acupuncture for breathlessness in advanced diseases: methodological issues. J Pain Symptom Manage. 2020;59:e3–4.</Citation><ArticleIdList><ArticleId IdType="pubmed">31805365</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung EL, Pan HD, Huang YF, et al. . The scientific foundation of Chinese herbal medicine against COVID-19. Engineering (Beijing). 2020;6:1099–107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833648</ArticleId><ArticleId IdType="pubmed">33520331</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Qin W, Wu L, et al. . A review of Chinese medicine for the treatment of psoriasis: principles, methods and analysis. Chin Med. 2021;16:138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8686297</ArticleId><ArticleId IdType="pubmed">34930402</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo XH, Zhu Y, Mao J, Du RC. T cell immunobiology and cytokine storm of COVID-19. Scand J Immunol. 2021;93:e12989.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7645942</ArticleId><ArticleId IdType="pubmed">33113222</ArticleId></ArticleIdList></Reference><Reference><Citation>Covid-19 Multi-omics Blood ATlas (COMBAT) Consortium. A blood atlas of COVID-19 defines hallmarks of disease severity and specificity. Cell. 2022;185:916–38.e958.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8776501</ArticleId><ArticleId IdType="pubmed">35216673</ArticleId></ArticleIdList></Reference><Reference><Citation>Krämer B, Knoll R, Bonaguro L, et al. . Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19. Immunity. 2021;54:2650–69.e14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8416549</ArticleId><ArticleId IdType="pubmed">34592166</ArticleId></ArticleIdList></Reference><Reference><Citation>Fathi N, Rezaei N. Lymphopenia in COVID-19: therapeutic opportunities. Cell Biol Int. 2020;44:1792–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7283672</ArticleId><ArticleId IdType="pubmed">32458561</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang H, Li J. “Lymphocyte * Neutrophil” count decreased in SARS-CoV-2 omicron patients in Shanghai with no significant change in CRP and SAA. J Clin Lab Anal. 2022;36:e24671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9538033</ArticleId><ArticleId IdType="pubmed">35989532</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimi A, Shobeiri P, Kulasinghe A, Rezaei N. Novel systemic inflammation markers to predict COVID-19 prognosis. Front Immunol. 2021;12:741061.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8569430</ArticleId><ArticleId IdType="pubmed">34745112</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Li L, Xu M, et al. . Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 2020;127:104370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194648</ArticleId><ArticleId IdType="pubmed">32344321</ArticleId></ArticleIdList></Reference><Reference><Citation>Smilowitz NR, Kunichoff D, Berger JS, et al. . C-reactive protein and clinical outcomes in patients with COVID-19. Eur Heart J. 2021;42:2270–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7928982</ArticleId><ArticleId IdType="pubmed">33448289</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai Y, Yue Y, Li J, Wang H. Mechanism of moxibustion in preventing and treating novel coronavirus disease 2019 (in Chinese). Chin J Ethnomed Ethnopharm. 202;29:88–89,99.</Citation></Reference><Reference><Citation>Li X, Lu H, Hu H, et al. . Possible mechanism of acupuncture and moxibustion in prevention and treatment of COVID-19 (in Chinese). Negative. 2020;11:9–12.</Citation></Reference><Reference><Citation>He W, Shi X-S, Zhang Z-Y, et al. . Discussion on the effect pathways of preventing and treating coronavirus disease 2019 by acupuncture and moxibustion from the regulation of immune inflammatory response (in Chinese). Chin Acupunct Moxibustion. 2020;40:799–802,809.</Citation><ArticleIdList><ArticleId IdType="pubmed">32869585</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Qiao L, Fan C, Guan X. Theoretical discussion on the application of moxibustion in the prophylaxis and treatment in corona virus disease 2019 (in Chinese). J Liaoning Univ Tradit Chin Med. 2020;22:174–7.</Citation></Reference><Reference><Citation>Lan L, Tao J, Chen A, et al. . Electroacupuncture exerts anti-inflammatory effects in cerebral ischemia-reperfusion injured rats via suppression of the TLR4/NF-κB pathway. Int J Mol Med. 2013;31:75–80.</Citation><ArticleIdList><ArticleId IdType="pubmed">23165960</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismail LA, Ibrahim AA, Abdel-Latif GA, et al. . Effect of acupuncture on body weight reduction and inflammatory mediators in egyptian obese patients. Open Access Maced J Med Sci. 2015;3:85–90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4877795</ArticleId><ArticleId IdType="pubmed">27275202</ArticleId></ArticleIdList></Reference><Reference><Citation>Herold T, Jurinovic V, Arnreich C, et al. . Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. J Allergy Clin Immunol. 2020;146:128–36.e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7233239</ArticleId><ArticleId IdType="pubmed">32425269</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>